Zobrazeno 1 - 10 of 6 966 pro vyhledávání: '"Johnstone RW"'
1
Akademický článek
Mapping the IMiD-dependent cereblon interactome using BioID-proximity labelling.
Autor: Costacurta M; Monash Haematology, Monash Health, Clayton, Australia.; Blood Cancer Therapeutics Laboratory, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia., Sandow JJ; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Australia., Maher B; Monash Haematology, Monash Health, Clayton, Australia.; Blood Cancer Therapeutics Laboratory, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia., Susanto O; Monash Haematology, Monash Health, Clayton, Australia.; Blood Cancer Therapeutics Laboratory, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia., Vervoort SJ; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., Devlin JR; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Garama D; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Australia., Condina MR; Mass Dynamics, Melbourne, Australia.; Clinical & Health Sciences, University of South Australia, Adelaide, Australia., Steele JR; Monash Proteomics and Metabolomics Platform, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia.; Monash Bioinformatics Platform, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia., Kahrood HV; Monash Proteomics and Metabolomics Platform, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia., Gough D; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Australia., Johnstone RW; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Shortt J; Monash Haematology, Monash Health, Clayton, Australia.; Blood Cancer Therapeutics Laboratory, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.
Publikováno v: The FEBS journal [FEBS J] 2024 Nov; Vol. 291 (22), pp. 4892-4912. Date of Electronic Publication: 2024 Jul 08.
Zobrazit plný text záznamu
2
Akademický článek
RNA kinetics influence the response to transcriptional perturbation in leukaemia cell lines.
Autor: Todorovski I; Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria 3010, Australia., Tsang MJ; Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria 3010, Australia., Feran B; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Australia., Fan Z; Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria 3010, Australia., Gadipally S; Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Yoannidis D; Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Kong IY; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Australia., Bjelosevic S; Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria 3010, Australia., Rivera S; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia., Voulgaris O; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia., Zethoven M; Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Hawkins ED; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Australia., Simpson KJ; Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria 3010, Australia., Arnau GM; Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria 3010, Australia., Papenfuss AT; Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria 3010, Australia.; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Australia., Johnstone RW; Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria 3010, Australia., Vervoort SJ; Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria 3010, Australia.; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Australia.
Publikováno v: NAR cancer [NAR Cancer] 2024 Oct 03; Vol. 6 (4), pp. zcae039. Date of Electronic Publication: 2024 Oct 03 (Print Publication: 2024).
Zobrazit plný text záznamu
3
Akademický článek
PRMT1 acts as a suppressor of MHC-I and anti-tumor immunity.
Autor: Djajawi TM; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Pijpers L; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Srivaths A; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Chisanga D; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Chan KF; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Hogg SJ; Oncology Discovery, AbbVie, South San Francisco, CA 94080, USA., Neil L; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Rivera SM; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia., Bartonicek N; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Ellis SL; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Lim Kam Sian TCC; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; Monash Proteomics and Metabolomics Platform, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3800, Australia; Department of Molecular and Translational Science, Faculty of Medicine, Nursing and Health Science, Monash University, Clayton, VIC 3168, Australia., Faridi P; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC 3168, Australia; Monash Proteomics and Metabolomics Platform, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3800, Australia; Department of Molecular and Translational Science, Faculty of Medicine, Nursing and Health Science, Monash University, Clayton, VIC 3168, Australia., Liao Y; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Pal B; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Behren A; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Shi W; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Vervoort SJ; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia., Johnstone RW; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Kearney CJ; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia. Electronic address: conor.kearney@onjcri.org.au.
Publikováno v: Cell reports [Cell Rep] 2024 Mar 26; Vol. 43 (3), pp. 113831. Date of Electronic Publication: 2024 Feb 23.
Zobrazit plný text záznamu
5
Akademický článek
A novel MYB::PAIP1 oncogenic fusion in pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN) is dependent on BCL2 expression and is sensitive to venetoclax.
Autor: Kosasih HJ; Murdoch Children's Research Institute Parkville Victoria Australia.; Children's Cancer Institute, Lowy Cancer Research Centre UNSW Sydney Kensington New South Wales Australia., Healey G; The Walter and Eliza Hall Institute of Medical Research Parkville Victoria Australia.; Olivia Newton-John Cancer Research Institute Heidelberg Victoria Australia., Brennan MS; The Walter and Eliza Hall Institute of Medical Research Parkville Victoria Australia.; Department of Medicine Huddinge, Centre for Haematology and Regenerative Medicine Karolinska Institutet Stockholm Sweden., Bjelosevic S; Peter MacCallum Cancer Centre Melbourne Victoria Australia.; The Sir Peter MacCallum Department of Oncology University of Melbourne Parkville Victoria Australia., Sadras T; Peter MacCallum Cancer Centre Melbourne Victoria Australia.; The Sir Peter MacCallum Department of Oncology University of Melbourne Parkville Victoria Australia., Jalud FB; Peter MacCallum Cancer Centre Melbourne Victoria Australia., Ibnat T; Peter MacCallum Cancer Centre Melbourne Victoria Australia., Ng AP; The Walter and Eliza Hall Institute of Medical Research Parkville Victoria Australia.; The Sir Peter MacCallum Department of Oncology University of Melbourne Parkville Victoria Australia.; Department of Biology The University of Melbourne Parkville Victoria Australia., Mayoh C; Children's Cancer Institute, Lowy Cancer Research Centre UNSW Sydney Kensington New South Wales Australia., Mao J; Children's Cancer Institute, Lowy Cancer Research Centre UNSW Sydney Kensington New South Wales Australia., Tax G; Children's Cancer Institute, Lowy Cancer Research Centre UNSW Sydney Kensington New South Wales Australia.; School of Clinical Medicine, UNSW Medicine & Health UNSW Sydney Sydney New South Wales Australia., Ludlow LEA; Murdoch Children's Research Institute Parkville Victoria Australia.; Department of Paediatrics University of Melbourne Parkville Victoria Australia., Johnstone RW; Peter MacCallum Cancer Centre Melbourne Victoria Australia.; The Sir Peter MacCallum Department of Oncology University of Melbourne Parkville Victoria Australia., Herold MJ; The Walter and Eliza Hall Institute of Medical Research Parkville Victoria Australia.; Olivia Newton-John Cancer Research Institute Heidelberg Victoria Australia.; Department of Medical Biology University of Melbourne Parkville Victoria Australia.; School of Cancer Medicine La Trobe University Heidelberg Victoria Australia., Khaw SL; Murdoch Children's Research Institute Parkville Victoria Australia., de Bock CE; Children's Cancer Institute, Lowy Cancer Research Centre UNSW Sydney Kensington New South Wales Australia.; School of Women's and Children's Health UNSW Sydney Kensington New South Wales Australia., Ekert PG; Children's Cancer Institute, Lowy Cancer Research Centre UNSW Sydney Kensington New South Wales Australia.; Peter MacCallum Cancer Centre Melbourne Victoria Australia.; The Sir Peter MacCallum Department of Oncology University of Melbourne Parkville Victoria Australia.; School of Clinical Medicine, UNSW Medicine & Health UNSW Sydney Sydney New South Wales Australia.
Publikováno v: HemaSphere [Hemasphere] 2024 Feb 14; Vol. 8 (2), pp. e1. Date of Electronic Publication: 2024 Feb 14 (Print Publication: 2024).
Zobrazit plný text záznamu
6
Akademický článek
A 2A R eGFP reporter mouse enables elucidation of A 2A R expression dynamics during anti-tumor immune responses.
Autor: Todd KL; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia. Kirsten.Todd@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia. Kirsten.Todd@petermac.org., Lai J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Sek K; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Huang YK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Newman DM; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Derrick EB; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Koay HF; Department of Microbiology & Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Melbourne, VIC, Australia., Nguyen D; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Hoang TX; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Petley EV; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Chan CW; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Munoz I; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., House IG; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Lee JN; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Kim JS; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Li J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Tong J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., N de Menezes M; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Scheffler CM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Yap KM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Chen AXY; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Dunbar PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Haugen B; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Parish IA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia., Johnstone RW; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.; Department of Immunology, Monash University, Clayton, Australia., Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia. paul.beavis@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia. paul.beavis@petermac.org.
Publikováno v: Nature communications [Nat Commun] 2023 Nov 01; Vol. 14 (1), pp. 6990. Date of Electronic Publication: 2023 Nov 01.
Zobrazit plný text záznamu
7
Akademický článek
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphoma.
Autor: Oh DH; Blood Cancer Therapeutics Laboratory, School of Clinical Sciences at Monash Health, Faculty of Medicine Nursing and Health Sciences, Monash University, Melbourne VIC 3168, Australia.; Monash Haematology, Monash Health, Melbourne VIC 3168, Australia.; Cancer Biology Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne VIC 3000, Australia., Ma X; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville VIC 3052, Australia.; Department of Systems Biology, Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115., Hogg SJ; Cancer Biology Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne VIC 3000, Australia.; Oncology Discovery Research, Abbvie, South San Francisco, CA 94080., He J; Blood Cancer Therapeutics Laboratory, School of Clinical Sciences at Monash Health, Faculty of Medicine Nursing and Health Sciences, Monash University, Melbourne VIC 3168, Australia.; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville VIC 3052, Australia., Kearney C; Olivia Newton-John Cancer Research Institute, Heidelberg VIC 3084, Australia.; School of Cancer Medicine, La Trobe University, Heidelberg VIC 3084, Australia., Brasacchio D; Blood Cancer Therapeutics Laboratory, School of Clinical Sciences at Monash Health, Faculty of Medicine Nursing and Health Sciences, Monash University, Melbourne VIC 3168, Australia., Susanto O; Blood Cancer Therapeutics Laboratory, School of Clinical Sciences at Monash Health, Faculty of Medicine Nursing and Health Sciences, Monash University, Melbourne VIC 3168, Australia., Maher B; Blood Cancer Therapeutics Laboratory, School of Clinical Sciences at Monash Health, Faculty of Medicine Nursing and Health Sciences, Monash University, Melbourne VIC 3168, Australia., Jennings IG; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville VIC 3052, Australia., Newbold A; Cancer Biology Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne VIC 3000, Australia.; Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Melbourne VIC 3000, Australia., Fraser P; Cancer Biology Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne VIC 3000, Australia.; Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Melbourne VIC 3000, Australia., Gruber E; Cancer Biology Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne VIC 3000, Australia.; Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Melbourne VIC 3000, Australia., Kats LM; Cancer Biology Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne VIC 3000, Australia.; Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Melbourne VIC 3000, Australia., Gregory GP; Blood Cancer Therapeutics Laboratory, School of Clinical Sciences at Monash Health, Faculty of Medicine Nursing and Health Sciences, Monash University, Melbourne VIC 3168, Australia.; Monash Haematology, Monash Health, Melbourne VIC 3168, Australia.; Cancer Biology Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne VIC 3000, Australia., Johnstone RW; Cancer Biology Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne VIC 3000, Australia.; Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Melbourne VIC 3000, Australia., Thompson PE; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville VIC 3052, Australia., Shortt J; Blood Cancer Therapeutics Laboratory, School of Clinical Sciences at Monash Health, Faculty of Medicine Nursing and Health Sciences, Monash University, Melbourne VIC 3168, Australia.; Monash Haematology, Monash Health, Melbourne VIC 3168, Australia.; Cancer Biology Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne VIC 3000, Australia.; Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Melbourne VIC 3000, Australia.
Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 Sep 05; Vol. 120 (36), pp. e2306414120. Date of Electronic Publication: 2023 Aug 29.
Zobrazit plný text záznamu
8
Akademický článek
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity.
Autor: House IG; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia. Electronic address: imran.house@petermac.org., Derrick EB; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Sek K; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Chen AXY; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Li J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Lai J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Todd KL; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Munoz I; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Michie J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Chan CW; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Huang YK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Chan JD; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Petley EV; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Tong J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Nguyen D; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Engel S; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia; Institute of Experimental Immunology, University of Bonn, Bonn, Germany., Savas P; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia., Hogg SJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia., Vervoort SJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia., Kearney CJ; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia., Burr ML; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia; Department of Anatomical Pathology, The Royal Melbourne Hospital, Melbourne, VIC 3050, Australia., Lam EYN; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia., Gilan O; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia., Bedoui S; Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia; Institute of Experimental Immunology, University of Bonn, Bonn, Germany., Johnstone RW; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia., Dawson MA; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia; Department of Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC 3052, Australia; Centre for Cancer Research, The University of Melbourne, Melbourne, VIC 3000, Australia., Loi S; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia., Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Department of Immunology, Monash University, Clayton, VIC, Australia. Electronic address: phil.darcy@petermac.org., Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia. Electronic address: paul.beavis@petermac.org.
Publikováno v: Cell reports [Cell Rep] 2023 Aug 29; Vol. 42 (8), pp. 113014. Date of Electronic Publication: 2023 Aug 21.
Zobrazit plný text záznamu
9
Akademický článek
BET Inhibition Enhances TNF-Mediated Antitumor Immunity.
Autor: Wellinger LC; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland., Hogg SJ; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Newman DM; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Friess T; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Geiss D; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Michie J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Ramsbottom KM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Bacac M; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Zurich, Schlieren, Switzerland., Fauti T; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Zurich, Schlieren, Switzerland., Marbach D; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland., Jarassier L; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland., Thienger P; Department for BioMedical Research, University of Bern, Bern, Switzerland., Paehler A; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland., Cluse LA; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Kearney CJ; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Vervoort SJ; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Trapani JA; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Oliaro J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Shortt J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Monash Haematology, Monash Health, Clayton, Australia.; School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia., Ruefli-Brasse A; Pfizer, South San Francisco, California., Rohle D; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland. drohle@ridgelinediscovery.com ricky.johnstone@petermac.org., Johnstone RW; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia. drohle@ridgelinediscovery.com ricky.johnstone@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.
Publikováno v: Cancer immunology research [Cancer Immunol Res] 2022 Jan; Vol. 10 (1), pp. 87-107. Date of Electronic Publication: 2021 Nov 15.
Zobrazit plný text záznamu
10
Akademický článek
Epigenetic modulators of B cell fate identified through coupled phenotype-transcriptome analysis.
Autor: Kong IY; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, 3010, VIC, Australia., Trezise S; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, 3010, VIC, Australia., Light A; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, 3010, VIC, Australia., Todorovski I; Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Arnau GM; Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia., Gadipally S; Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia., Yoannidis D; Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia., Simpson KJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Dong X; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, 3010, VIC, Australia., Whitehead L; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, 3010, VIC, Australia., Tempany JC; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, 3010, VIC, Australia., Farchione AJ; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, 3010, VIC, Australia., Sheikh AA; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia., Groom JR; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, 3010, VIC, Australia., Rogers KL; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, 3010, VIC, Australia., Herold MJ; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, 3010, VIC, Australia., Bryant VL; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, 3010, VIC, Australia., Ritchie ME; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, 3010, VIC, Australia., Willis SN; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, 3010, VIC, Australia., Johnstone RW; Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Hodgkin PD; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, 3010, VIC, Australia., Nutt SL; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, 3010, VIC, Australia., Vervoort SJ; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia. vervoort.s@wehi.edu.au.; Department of Medical Biology, The University of Melbourne, Parkville, 3010, VIC, Australia. vervoort.s@wehi.edu.au.; Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia. vervoort.s@wehi.edu.au.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia. vervoort.s@wehi.edu.au., Hawkins ED; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, VIC, Australia. Hawkins.e@wehi.edu.au.; Department of Medical Biology, The University of Melbourne, Parkville, 3010, VIC, Australia. Hawkins.e@wehi.edu.au.
Publikováno v: Cell death and differentiation [Cell Death Differ] 2022 Dec; Vol. 29 (12), pp. 2519-2530. Date of Electronic Publication: 2022 Jul 13.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje